Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 16, 2007. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically detailing changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and does not contain financial performance data.
Material Changes
The material change reported is the purchase of Ordinary Shares by two individuals on April 12, 2007, under a Single Company ISA at a price of GBP 14.10 per share:
- Mr. J S Heslop: 6 shares
- Mr. A P Witty: 5 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to disclosure rules regarding director share transactions.
Key Facts for Investor Verification
- Transaction Date: April 12, 2007
- Share Price: GBP 14.10 per Ordinary Share
- Participants: Mr. J S Heslop and Mr. A P Witty
- Notification Date: April 16, 2007
- Regulatory Basis: Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b)